These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 18060817

  • 1. The role of collagenases in experimental pulmonary fibrosis.
    Ouchi H, Fujita M, Ikegame S, Ye Q, Inoshima I, Harada E, Kuwano K, Nakanishi Y.
    Pulm Pharmacol Ther; 2008; 21(2):401-8. PubMed ID: 18060817
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
    Corbel M, Caulet-Maugendre S, Germain N, Molet S, Lagente V, Boichot E.
    J Pathol; 2001 Apr; 193(4):538-45. PubMed ID: 11276015
    [Abstract] [Full Text] [Related]

  • 3. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
    Okuma T, Terasaki Y, Kaikita K, Kobayashi H, Kuziel WA, Kawasuji M, Takeya M.
    J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immunohistochemical and gelatin zymography studies for matrix metalloproteinases in bleomycin-induced pulmonary fibrosis.
    Yaguchi T, Fukuda Y, Ishizaki M, Yamanaka N.
    Pathol Int; 1998 Dec; 48(12):954-63. PubMed ID: 9952339
    [Abstract] [Full Text] [Related]

  • 7. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
    Fujita M, Mizuta Y, Ikegame S, Ouchi H, Ye Q, Harada E, Inoshima I, Yoshimi M, Watanabe K, Nakanishi Y.
    Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
    [Abstract] [Full Text] [Related]

  • 8. Influence of early neutrophil depletion on MMPs/TIMP-1 balance in bleomycin-induced lung fibrosis.
    Manoury B, Nénan S, Guénon I, Lagente V, Boichot E.
    Int Immunopharmacol; 2007 Jul; 7(7):900-11. PubMed ID: 17499192
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early and late changes of MMP-2 and MMP-9 in bleomycin-induced pulmonary fibrosis.
    Kim JY, Choeng HC, Ahn C, Cho SH.
    Yonsei Med J; 2009 Feb 28; 50(1):68-77. PubMed ID: 19259351
    [Abstract] [Full Text] [Related]

  • 13. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis.
    Manoury B, Nenan S, Leclerc O, Guenon I, Boichot E, Planquois JM, Bertrand CP, Lagente V.
    Respir Res; 2005 Jan 21; 6(1):11. PubMed ID: 15663794
    [Abstract] [Full Text] [Related]

  • 14. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C, Shiota N, Okunishi H.
    Eur J Pharmacol; 2011 Jan 10; 650(1):424-30. PubMed ID: 21034736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.